Calyx, Qynapse to partner on AI to analyze brain scans

2020 02 21 17 18 9566 Business Handshake Woman 400

Calyx and artificial intelligence (AI) neuroimaging technology firm Qynapse plan to collaborate on making Qynapse's QyScore and QyPredict algorithms available to customers developing medical treatments for central nervous system disorders.

QyScore and QyPredict help clinicians analyze and interpret brain scans, helping them determine the best treatment for conditions such as multiple sclerosis, Parkinson's, Alzheimer's, and Huntington's diseases, Calyx said.

Page 1 of 605
Next Page